- All address
- BFA,Main Hall 1/2-A,Level 2
- BFA,The Pavilion
- BFA,Dong Yu Grand Ballroom A
- BFA,Dong Yu Grand Ballroom B
- BFA,Dong Yu Grand Ballroom C
- BFA,Dong Yu Grand Ballroom D
- Peacock Room 1
- Oriental Theatre
- ALL
- 1-2：Standards Seminar
- 4-1：Clinical Evidence for Sports Nutrition Foods and Health
- 4-2：New Product Development in Sports Nutrition
- 5-1：New FSMP Policies Driving New Quality Productive Forces
- 5-2：Industry Empowerment：New Horizons for FSMP
- 5-3：Roundtable Discussion：
- 6-6：Microbiome Balance and Host Health:From Mechanisms to Applications
- 6-7：Prebiotics and Host Health:From Mechanisms to Applications
- 6-8：Next-Generation Probiotics:Akkermansia muciniphila (AKK)
- 7-1：Whole Grain Foods and Healthy Development
- 8-1：Breast Milk Research and Innovative Ingredient Development
- 8-2：Industrial Translation and Clinical Evidence
Sessions
Section I：Food Regulations and Standards - Session 2：Standards Seminar |
2027-02-25 09:00-12:10 |
| 2027-02-25 09:00-09:30 15th Five-Year Plan for National Food Safety StandardsDepartment of Food Safety,National Health Commission |
| 2027-02-25 09:30-09:50 Research on the Standardization System of Special Foods and Key PrioritiesZhong Qiding,Professor-level Senior Engineer,Secretary-General,National Special Food Standardization Committee |
| 2027-02-25 09:50-10:10 Introduction to National Standards for Food Nutrition ManagementWang Zhutian,Research Fellow,Secretary-General,National Food Nutrition and Health Management Standardization Working Group |
| 2027-02-25 10:10-10:30 Key Priorities for Nutrition Standards in the 15th Five-Year PlanNutrition Standards Committee,National Health Standards Committee |
| 2027-02-25 10:30-10:50 Interpretation of Nutritional Fortificant Usage StandardsLi Huzhong,Associate Research Fellow,China National Center for Food Safety Risk Assessment |
| 2027-02-25 10:50-11:10 Interpretation of Sports Nutrition Food StandardsFang Haiqin,Research Fellow,Director of Applied Nutrition Division I,China National Center for Food Safety Risk Assessment |
| 2027-02-25 11:10-12:10 Q&A |
Section IV：Sports Foods - Session 1：Clinical Evidence for Sports Nutrition Foods and Health |
2027-02-25 08:30-10:20 |
| 2027-02-25 08:30-08:40 Opening AddressTBC |
| 2027-02-25 08:40-09:00 PepsiCo R&DTBC |
| 2027-02-25 09:00-09:20 Whey Protein for Endurance Exercise:2027 updateElisa Glover |
| 2027-02-25 09:20-09:40 Human Clinical Study of High-Purity β-Lactoglobulin:Latest Results on Muscle Health (Tentative)Hye-Jin Kim |
| 2027-02-25 09:40-10:00 Micronutrient Status in High-Level Athletic Populations — A Cross-Sectional Study |
| 2027-02-25 10:00-10:20 Title TBC (Clinical Evidence)Sports Nutrition Engineering Research Center,Beijing Sport University |
Section IV：Sports Foods - Session 2：New Product Development in Sports Nutrition |
2027-02-25 10:20-12:00 |
| 2027-02-25 10:20-10:40 Clinical Practice of Synthetic Biology Functional Ingredients in Sports NutritionWilliam Hung |
| 2027-02-25 10:40-11:00 How Caseinates can break through in a Whey-Dominated Sports Nutrition MarketFrieslandCampina |
| 2027-02-25 11:00-11:20 Starting with Creatine:Ushering in a New Era of Lightweight Sports Nutrition GummiesZhao Dandan,Marketing Director,Yichao Health / Guangdong Yichao Biotechnology Co.,Ltd. |
| 2027-02-25 11:20-11:40 Theme TBCMengniu Masseng |
| 2027-02-25 11:40-12:00 Theme TBCCPT |
Section V：Foods for Special Medical Purposes (FSMPs)——Session 1：New FSMP Policies Driving New Quality Productive Forces |
2027-02-25 09:00-10:15 |
| 2027-02-25 09:00-09:15 Expert Introductory Remarks:The Urgent Need for Open Clinical Application of FSMP Foods |
| 2027-02-25 09:15-09:30 Overview of FSMP Policy Dynamics and Application Status |
| 2027-02-25 09:30-09:45 Proposed:Inspection Cases and Technical Points of the Special Food SystemFood Inspection Center Expert,Special Food Technical Department |
| 2027-02-25 09:45-10:00 Proposed:Outlook on Digital Coding Applications in the Special Food SectorCoding Center Expert,Coding Center |
| 2027-02-25 10:00-10:15 Pioneer Practices in Special Food ImplementationRepresentative,Hainan Lecheng Pilot Zone Administration |
Section V：Foods for Special Medical Purposes (FSMPs)——Session 2：Industry Empowerment：New Horizons for FSMP |
2027-02-25 10:15-12:15 |
| 2027-02-25 10:15-10:30 Proposed:Application of Special Foods in Dietary Weight ManagementInvited:Prof. Chen Wei,Peking Union Medical College Hospital / Nestlé Health Science |
| 2027-02-25 10:30-10:45 Nestlé Health Science's Exploration in DigitalizationZhang Qiyan,Nestlé Health Science |
| 2027-02-25 10:45-11:00 Clinical Studies on Cognitive Enhancement ProductsNutricia Speaker,Danone Nutricia |
| 2027-02-25 11:00-11:15 Protein Research in Female PopulationsFrieslandCampina Speaker,FrieslandCampina Food Ingredients |
| 2027-02-25 11:15-11:30 Clinical Study on Nutritional Supplement Products for Dialysis and Nephropathy at West China HospitalGardner Speaker,Gardner FSMP |
| 2027-02-25 11:30-11:45 Abbott TopicAbbott Speaker,Abbott |
| 2027-02-25 11:45-12:00 Shengtong TopicShengtong Speaker,Shengtong FSMP |
| 2027-02-25 12:00-12:15 Application of Hydrolyzed Casein in FSMP FoodsKingsa Speaker,Kingsa Dairy |
Section V：Foods for Special Medical Purposes (FSMPs)——Roundtable Discussion： |
2027-02-25 12:15-12:45 |
Section VI：Probiotics,Prebiotics and Postbiotics - Session 6：Microbiome Balance and Host Health:From Mechanisms to Applications |
2027-02-25 09:00-11:40 |
| |
| 2027-02-25 09:00-09:20 Next-Generation Probiotic Screening Strategies and R&D Pathways Targeting Immune Regulation |
| 2027-02-25 09:20-09:40 Dietary Live Microorganism Intake Status and Health Associations Among Chinese Residents |
| 2027-02-25 09:40-10:00 Gut-Musculoskeletal Axis:New Opportunities for Probiotics in Bone,Joint,and Mobility Health |
| 2027-02-25 10:00-10:20 Scientific Evidence of Probiotic Lactobacillus casei Strain Shirota (LcS)Yakult |
| 2027-02-25 10:20-10:40 From Lab to Clinic:The Systematic Scientific Evidence Journey of Lacticaseibacillus rhamnosus CRL1505Sacco System,Italy |
| 2027-02-25 10:40-11:00 Multimodal Digital Approaches in Microbiome Research:From Baseline Stratification to Intervention Trial Evaluation |
| 2027-02-25 11:00-11:20 Mechanistic Foundations and Clinical Evidence of Liposomal Bupivacaine |
| 2027-02-25 11:20-11:40 ADM Enabling New Postbiotic Opportunities:Cutting-Edge Postbiotic Solutions from a White Paper Perspective |
Section VI：Probiotics,Prebiotics and Postbiotics - Session 7：Prebiotics and Host Health:From Mechanisms to Applications |
2027-02-25 09:00-10:20 |
| |
Section VI：Probiotics,Prebiotics and Postbiotics - Session 8：Next-Generation Probiotics:Akkermansia muciniphila (AKK) |
2027-02-25 13:30-15:50 |
| |
| 2027-02-25 13:30-13:50 Domestic and International Research Progress and Industrialization Status of Akkermansia muciniphila (AKK)Lu Wenwei,Vice Dean,School of Food Science and Technology,Jiangnan University |
| 2027-02-25 13:50-14:10 Research Progress on AKK Safety:A Systematic Review Based on Preclinical and Clinical EvidenceChina National Center for Food Safety Risk Assessment |
| 2027-02-25 14:10-14:30 Next-Generation Probiotic:Development and Application of Akkermansia muciniphila Akk11 in Metabolic Health RegulationLiu Litai,R&D Manager,Weikan Probiotics (Suzhou) Co.,Ltd. |
| 2027-02-25 14:30-14:50 Akkermansia muciniphila MucT®:How a scientific discovery becomes a leading innovation?Dr Anneleen Segers,Senior Scientist,The Akkermansia Company (part of Danone Group) |
| 2027-02-25 14:50-15:10 Mechanistic Study of AKK ONE Strain in Improving Enteritis and Cognitive FunctionLi Nan,R&D Director,Sirio Pharma (China) Co.,Ltd. |
| 2027-02-25 15:10-15:30 Clinical Study of AKK Intervention in Obese,Overweight,and PCOS PopulationsProf. Chen Tingtao,Nanchang University |
| 2027-02-25 15:30-15:50 Mechanistic Exploration of AKK in Alzheimer's Disease ModelsProf. Ren Dayong,Jilin Agricultural University |
Section VII：Healthy Grains——Session 1：Whole Grain Foods and Healthy Development |
2027-02-25 08:00-12:00 |
| 2027-02-25 08:00-08:20 Introductory Report:2026 Review of Healthy Grain Development |
| 2027-02-25 08:20-08:40 Whole Grains and Proactive HealthProf. Shi Hanping,Department of Gastrointestinal Surgery,Beijing Shijitan Hospital |
| 2027-02-25 08:40-09:00 Whole Grain Innovation Empowering a Healthy Future:Opportunity Insights and Strategic Layout |
| 2027-02-25 09:00-09:20 Interpretation of Whole Grain Naming and Labeling Requirements (GB/T 48029-2026)Zhai Xiaotong,Associate Research Fellow,Academy of National Food and Strategic Reserves Administration |
| 2027-02-25 09:20-09:40 Study on Effects of Highland Barley Whole Grain Crispy Cereal on Glucose-Lipid Metabolism and Metabolic Inflammation |
| 2027-02-25 09:40-10:00 Whole Grains and Gut HealthAi Lianzhong,Shanghai Jiao Tong University |
| 2027-02-25 10:00-10:20 Review of Typical Cases of Whole Grain Development in China 2025-2026Zhi Zhenhua,Publicity and Education Center,National Food and Strategic Reserves Administration |
| 2027-02-25 10:20-10:40 New Developments in Quinoa ResearchLiu Chenghong,Shanghai Academy of Agricultural Sciences |
| 2027-02-25 10:40-11:00 Whole-Chain Perspective on Health Grain Innovation and PracticeYing Xin,COFCO Grain Science and Technology Innovation Department |
| 2027-02-25 11:00-12:00 Roundtable:Whole Grain Standardization Driving the Implementation of the National Whole Grain Action PlanModerator: |
Section VIII：Infant Nutrition——Session 1：Breast Milk Research and Innovative Ingredient Development |
2027-02-25 09:00-11:40 |
| 2027-02-25 09:00-09:20 Scientific Discovery,Functional Research,and Industrial Innovation of Milk-Derived Active ProteinsTBC |
| 2027-02-25 09:20-09:40 Breast Milk-Derived Probiotic YLGB1496:Strain Characteristics,Scientific Evidence,and Innovative ApplicationsTBC |
| 2027-02-25 09:40-10:00 Source Innovation,Dual Freshness Empowerment:Research and Application of Native Milk Proteins and Active Milk LipidsTBC |
| 2027-02-25 10:00-10:20 A Novel Strain for Infants and Young Children:From Scientific Evidence to Industrial Application in Infant Formula and Children's FoodsSun Zhiping,Director,The Second Affiliated Hospital of Nanjing Medical University |
| 2027-02-25 10:20-10:40 New Breakthroughs in the HMO Era — Effects of Synbiotic Combinations on Infant Gut Health |
| 2027-02-25 10:40-11:00 Early-Life Protein Optimization and Application Exploration |
| 2027-02-25 11:00-11:20 Decoding the Science of HMO Combinations and Synergistic Synbiotics (HMO + Probiotics) to Support Infant Formula Upgrading |
| 2027-02-25 11:20-11:40 Next-Generation GOS:Emerging Scientific Evidence and Opportunities |
Section VIII：Infant Nutrition——Session 2：Industrial Translation and Clinical Evidence |
2027-02-25 14:00-17:00 |
| 2027-02-25 14:00-14:20 From 'Simulation' to 'Evidence':Clinical Translation and Benefits of HMOs in Infant FormulaTBC |
| 2027-02-25 14:20-14:40 Clinical Study on Growth,Development,and Safety of Preterm Infant Formula in Preterm InfantsTBC |
| 2027-02-25 14:40-15:00 Clinical Practice and Challenges of Partially Hydrolyzed Protein FormulasTBC |
| 2027-02-25 15:00-15:20 Mixed Research Report on Effects of Different Feeding Methods on Allergy Prevention and Digestion-Absorption in InfantsTBC |
| 2027-02-25 15:20-15:40 Human Intervention Study of a Novel Strain:Probiotic Mechanisms and Evidence System for Infants and Young ChildrenSun Zhiping,Director,Nanjing Medical University |
| 2027-02-25 15:40-16:00 From Breast Milk Inspiration to Clinical Validation:The Evidence-Based Pathway for Infant Nutrition Innovation |
| 2027-02-25 16:00-16:20 Nutritional Characteristics and Quality of Demineralized Sheep Whey Powder from a Human Milk Mimicry PerspectiveGeneral Manager,Laiteries Triballat Noyal (France),China Region |
| 2027-02-25 16:20-16:40 Scientific Feeding Strategies for Infant Formula with Partially Hydrolyzed Dual Protein |
| 2027-02-25 16:40-17:00 |